| Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer K Wang, ST Yuen, J Xu, SP Lee, HHN Yan, ST Shi, HC Siu, S Deng, ... Nature genetics 46 (6), 573-582, 2014 | 1078 | 2014 |
| Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming DK Gehlhaar, GM Verkhivker, PA Rejto, CJ Sherman, DR Fogel, LJ Fogel, ... Chemistry & biology 2 (5), 317-324, 1995 | 893 | 1995 |
| Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer K Wang, J Kan, ST Yuen, ST Shi, KM Chu, S Law, TL Chan, Z Kan, ... Nature genetics 43 (12), 1219-1223, 2011 | 857 | 2011 |
| Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma Z Kan, H Zheng, X Liu, S Li, TD Barber, Z Gong, H Gao, K Hao, ... Genome research 23 (9), 1422-1433, 2013 | 560 | 2013 |
| Deciphering common failures in molecular docking of ligand-protein complexes GM Verkhivker, D Bouzida, DK Gehlhaar, PA Rejto, S Arthurs, AB Colson, ... Journal of computer-aided molecular design 14, 731-751, 2000 | 303 | 2000 |
| Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma K Wang, HY Lim, S Shi, J Lee, S Deng, T Xie, Z Zhu, Y Wang, D Pocalyko, ... Hepatology 58 (2), 706-717, 2013 | 190 | 2013 |
| PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor K Wang, Q Zhang, D Li, K Ching, C Zhang, X Zheng, M Ozeck, S Shi, X Li, ... Clinical cancer research 21 (6), 1487-1496, 2015 | 168 | 2015 |
| Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine … PS Dragovich, TJ Prins, R Zhou, SE Webber, JT Marakovits, SA Fuhrman, ... Journal of medicinal chemistry 42 (7), 1213-1224, 1999 | 163 | 1999 |
| Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors W Zhong, JS Myers, F Wang, K Wang, J Lucas, E Rosfjord, J Lucas, ... Bmc Genomics 21, 1-17, 2020 | 131 | 2020 |
| Complexity and simplicity of ligand–macromolecule interactions: the energy landscape perspective GM Verkhivker, D Bouzida, DK Gehlhaar, PA Rejto, ST Freer, PW Rose Current opinion in structural biology 12 (2), 197-203, 2002 | 129 | 2002 |
| Docking conformationally flexible small molecules into a protein binding site through evolutionary programming DK Gehlhaar, G Verkhivker, PA Rejto, DB Fogel, LJ Fogel, ST Freer | 129 | 1995 |
| An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735 KE Hook, SJ Garza, ME Lira, KA Ching, NV Lee, J Cao, J Yuan, J Ye, ... Molecular cancer therapeutics 11 (3), 710-719, 2012 | 118 | 2012 |
| A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis IJ Bujalska, LL Gathercole, JW Tomlinson, C Darimont, J Ermolieff, ... The Journal of endocrinology 197 (2), 297, 2008 | 116 | 2008 |
| Simulating disorder–order transitions in molecular recognition of unstructured proteins: where folding meets binding GM Verkhivker, D Bouzida, DK Gehlhaar, PA Rejto, ST Freer, PW Rose Proceedings of the National Academy of Sciences 100 (9), 5148-5153, 2003 | 116 | 2003 |
| Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics CR Kissinger, PA Rejto, LA Pelletier, JA Thomson, RE Showalter, ... Journal of molecular biology 342 (3), 943-952, 2004 | 115 | 2004 |
| Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome YH Park, S Lal, JE Lee, YL Choi, J Wen, S Ram, Y Ding, SH Lee, E Powell, ... Nature communications 11 (1), 6175, 2020 | 108 | 2020 |
| Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity in Vivo Limits Glucocorticoid Exposure to Human Adipose Tissue and Decreases Lipolysis JW Tomlinson, M Sherlock, B Hughes, SV Hughes, F Kilvington, W Bartlett, ... The Journal of Clinical Endocrinology & Metabolism 92 (3), 857-864, 2007 | 105 | 2007 |
| Unraveling principles of lead discovery: from unfrustrated energy landscapes to novel molecular anchors. PA Rejto, GM Verkhivker Proceedings of the National Academy of Sciences 93 (17), 8945-8950, 1996 | 97 | 1996 |
| Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2 … PS Dragovich, TJ Prins, R Zhou, TO Johnson, Y Hua, HT Luu, SK Sakata, ... Journal of medicinal chemistry 46 (21), 4572-4585, 2003 | 93 | 2003 |
| A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations T Xie, G d’Ario, JR Lamb, E Martin, K Wang, S Tejpar, M Delorenzi, ... Public Library of Science 7 (7), e42001, 2012 | 92 | 2012 |
